These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27391967)

  • 21. Long-term outcome of heart transplantation performed after ventricular assist device compared with standard heart transplantation.
    Petroni T; D'Alessandro C; Combes A; Golmard JL; Brechot N; Barreda E; Laali M; Farahmand P; Varnous S; Weber P; Pavie A; Leprince P
    Arch Cardiovasc Dis; 2019; 112(8-9):485-493. PubMed ID: 31353279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
    Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of healthcare-associated infections in a pediatric population with an extracorporeal ventricular assist device.
    Fragasso T; Ricci Z; Grutter G; Albanese S; Varano C; Amodeo A; Cogo P
    Artif Organs; 2011 Nov; 35(11):1110-4. PubMed ID: 22097984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of pediatric ventricular assist devices and their neurologic and renal complications-A 24-year single-center experience.
    Mantell B; Addonizio L; Jain N; LaPar D; Chai P; Bacha E; Kalfa D; McAllister J; Zuckerman W; Lee T; Richmond M; Law S
    Artif Organs; 2020 Sep; 44(9):987-994. PubMed ID: 32279327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary outcomes of durable ventricular assist devices in adults with congenital heart disease as a bridge to heart transplantation.
    Das BB; Kogon B; Deshpande SR; Slaughter MS; Trivedi JR
    Artif Organs; 2022 Apr; 46(4):697-704. PubMed ID: 34698399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for prolonged mechanical ventilation for children on ventricular assist device support.
    Prodhan P; Kalikivenkata G; Tang X; Thomas K; Byrnes J; Imamura M; Jaquiss RD; Garcia X; Frazier EA; Bhutta AT; Dyamenahalli U
    Ann Thorac Surg; 2015 May; 99(5):1713-8. PubMed ID: 25754963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?
    Urban M; Pirk J; Dorazilova Z; Netuka I
    Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):405-9. PubMed ID: 21788304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early and mid-term outcomes of left ventricular assist device implantation and future prospects.
    Hata H; Fujita T; Shimahara Y; Sato S; Yanase M; Seguchi O; Sato T; Nakatani T; Kobayashi J
    Gen Thorac Cardiovasc Surg; 2015 Oct; 63(10):557-64. PubMed ID: 25802124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure.
    Anand J; Singh SK; Hernández R; Parnis SM; Civitello AB; Cohn WE; Mallidi HR
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):267-75, 278.e1. PubMed ID: 25312232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventricular Assist Device in Acute Myocardial Infarction.
    Acharya D; Loyaga-Rendon RY; Pamboukian SV; Tallaj JA; Holman WL; Cantor RS; Naftel DC; Kirklin JK
    J Am Coll Cardiol; 2016 Apr; 67(16):1871-80. PubMed ID: 27102502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.
    Lima B; Rajagopal K; Petersen RP; Shah AS; Soule B; Felker GM; Rogers JG; Lodge AJ; Milano CA
    Circulation; 2006 Jul; 114(1 Suppl):I27-32. PubMed ID: 16820584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of Infection and Antimicrobial Consumption in Ventricular Assist Device (VAD) Recipients at the Prince Charles Hospital (TPCH): A Retrospective Analysis.
    Belz S; Fisquet S; Ahuja A; Hay K; Lavana J
    Heart Lung Circ; 2020 Aug; 29(8):1234-1240. PubMed ID: 32179022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke and death risk in ventricular assist device patients varies by ISHLT infection category: An INTERMACS analysis.
    Shah P; Birk SE; Cooper LB; Psotka MA; Kirklin JK; Barnett SD; Katugaha SB; Phillips S; Looby MM; Pagani FD; Cowger JA
    J Heart Lung Transplant; 2019 Jul; 38(7):721-730. PubMed ID: 30954340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved survival after heart transplantation in patients with bridge to transplant in the recent era: a 17-year single-center experience.
    Osaki S; Edwards NM; Johnson MR; Velez M; Munoz A; Lozonschi L; Murray MA; Proebstle AK; Kohmoto T
    J Heart Lung Transplant; 2009 Jun; 28(6):591-7. PubMed ID: 19481020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracoporeal membrane oxygenation hybrid with Thoratec ventricular-assist devices as double bridge to heart transplantation.
    Chou NK; Chi NH; Wu IW; Huang SC; Chen YS; Yu HY; Tsao CI; Ko WJ; Chu SH; Wang SS
    Transplant Proc; 2010 Apr; 42(3):920-2. PubMed ID: 20430204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of patients with infection related to a ventricular assist device after heart transplantation.
    Moayedi Y; Multani A; Bunce PE; Henricksen E; Lee R; Yang W; Gomez CA; Garvert DW; Tremblay-Gravel M; Duclos S; Hiesinger W; Ross HJ; Khush KK; Montoya JG; Teuteberg JJ
    Clin Transplant; 2019 Oct; 33(10):e13692. PubMed ID: 31403741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Ventricular Assist Device-Specific Infections on Post-Heart Transplant Infections: A Retrospective Single-Center Study.
    Iwata N; Shibata SC; Yoshioka D; Uchiyama A; Toda K; Sawa Y; Fujino Y
    Transplant Proc; 2021 Dec; 53(10):3030-3035. PubMed ID: 34732298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the clinical effectiveness of the Ventricular Assist Device Program in the United Kingdom (EVAD UK).
    Sharples LD; Cafferty F; Demitis N; Freeman C; Dyer M; Banner N; Birks EJ; Khaghani A; Large SR; Tsui S; Caine N; Buxton M
    J Heart Lung Transplant; 2007 Jan; 26(1):9-15. PubMed ID: 17234511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of ventricular assist device as bridge to simultaneous heart and kidney transplantation in patients with cardiac and renal failure.
    Yanagida R; Czer LS; Ruzza A; Schwarz ER; Simsir SA; Jordan SC; Trento A
    Transplant Proc; 2013; 45(6):2378-83. PubMed ID: 23953551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.